Mark Hicar

Associate Professor

University at Buffalo

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Virology

40%

Immunology

60%

Sars-cov-2

30%

Antibodies

30%

Systemic Lupus Erythematosus

30%

Covid-19

20%

Coronavirus Disease

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

COVID-19 Positive Versus Negative Complete Kawasaki Disease: A Study from the International Kawasaki Disease Registry

Article Link

Year:

2023

Decreased Clinical Severity of Pediatric Acute COVID-19 and MIS-C and Increase of Incidental Cases during the Omicron Wave in Comparison to the Delta Wave

Article Link

Year:

2023

Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1

Article Link

Year:

2023

Kawasaki Disease in the Time of COVID-19 and MIS-C - The International Kawasaki Disease Registry

Article Link

Year:

2023

Presence of coronary aneurysms during Kawasaki Disease (KD) correlates with lower levels of autoantibodies to both full form and spliced variant of immune regulator Del-1

Article Link

Year:

2023

SARS-CoV-2 Variants and Multisystem Inflammatory Syndrome in Children

Article Link

Year:

2023

Antibody dependent cell cytotoxicity is maintained by the unmutated common ancestor of 6F5, a Gp41 conformational epitope targeting antibody that utilizes heavy chain VH1-2

Article Link

Year:

2022

Association of anti-HSC70 autoantibodies with cutaneous ulceration and severe disease in juvenile dermatomyositis

Article Link

Year:

2022

Clonal expansion and markers of directed mutation of IGHV4-34 B cells in plasmablasts during Kawasaki disease

Article Link

Year:

2022

Conformational plasticity of the HIV-1 gp41 immunodominant region is recognized by multiple non-neutralizing antibodies

Article Link

Year:

2022

Collaborators4

Hidemi Kajimoto

Oregon Health & Science University

UNITED STATES

Ashraf Harahsheh

Professor of Pediatrics

Nationwide Children's Hospital

UNITED STATES

Matthew Elias

Clinical Assistant Professor of Pediatrics, Pediatric Cardiology Attending Physician

Children's Hospital of Philadelphia

UNITED STATES

Seth H. Pincus

Montana State University

UNITED STATES

How do I reach out?

Meet Kite AI